About Paulina Hill
Paulina Hill is a director at Odyssey Therapeutics.
Form D filings also name Paulina Hill as a board member at NextPoint Therapeutics and a director at Avilar Therapeutics.
Paulina Hill reports to the SEC as a director of 3 public companies, including Neuronetics (STIM) and Kala Bio (KALA).
Paulina Hill first appears on SEC filings in 2017.
Experience
This experience comes from Paulina Hill's profile and from SEC filings. For roles taken from filings, the years are when the filings name Paulina Hill in the role, so the role may have started earlier or lasted longer.
WB
Windward Bio Current
Board Observer
2026 – Present
DT
Diagonal Therapeutics Current
Board Member
2026 – Present
QB
QuantX Biosciences Current
Board Observer
2025 – Present
AT
Attovia Therapeutics Current
Board Observer
2025 – Present
NI
Nuvig Therapeutics Inc. Current
Board Member
2024 – Present
TT
Tisento Therapeutics Current
Board Member
2023 – Present
ZB
Zag Bio Current
Board Observer
2023 – Present
NextPoint Therapeutics, Inc. Current
Board Member
2022 – Present · Cambridge, MA
Develops targeted cancer treatments for patients with solid tumors.
NO
Normunity Current
Board Observer
2022 – Present
SA
Sanofi Current
Partner at Sanofi Ventures
2022 – Present
AT
Aliada Therapeutics
Board Observer
2022 – 2024
ST
Scorpion Therapeutics
Board Observer
2020 – 2021
OF
Omega Funds
Principal
2019 – 2021
IT
IFM Therapeutics
Board Member
2019 – 2021
AT
Arrakis Therapeutics
Board Observer
2019 – 2021
NI
Neuronetics, Inc.
Director
2018 · Public company (STIM)
KI
Kala Bio, Inc.
Director
2017 – 2018 · Public company (KALA)
PP
Polaris Partners
Healthcare Investment Team
2012 – 2018
MI
MIT
Research Affiliate in Langer Lab, Department of Chemical Engineering
2012 – 2014
SP
Startup Leadership Program
Fellow and Co-Program Leader
2011 – 2012
Key Colleagues at Startups
The people Paulina Hill works with at each company, as listed on that company's latest Form D.
NextPoint Therapeutics, Inc. · Form D, Jul 30, 2026
Ivan Cheung
Chief Executive Officer and director
R. Jacob Vogelstein
Board Member
JL
Jeffrey Lacey
Secretary & Treasurer
Brian Shuster
Board Member
Detlev Biniszkiewicz
Chairman of the Board
Rakhshita Dhar
Board Member
Axel Hoos
Board Member
Odyssey Therapeutics, Inc. · Form D, Dec 4, 2025
VO
Valerie Odegard
Director
CG
Carl Gordon
Director
CN
Carolyn Ng
Director
GG
Gary Glick
President & CEO, director
TW
Timothy Walbert
Director
NL
Nan Li
Director
JL
Jeffrey Leiden
Director
JH
Jason Haas
CFO
NT
Nia Tatsis
Director
KP
Ksenija Pavletic
Director
SC
Shelley Chu
Director
LS
Lan Smith
Director
JC
Jill Carroll
Director
Avilar Therapeutics, Inc. · Form D/A, Feb 13, 2023
TC
Theresa Cameron
Director
MF
Martin Freed
Director
ST
Stephanie Tozzo
Executive officer
PG
Phil Graham
Executive officer
MD
Milind Deshpande
Director
DN
David Neafus
Executive officer
DG
Daniel Grau
President and director
AM
Adam Muzikant
Executive officer
JR
Joshua Resnick
Director